Real-life validation of the Panbio COVID-19 Antigen Rapid Test (Abbott) in community-dwelling subjects with symptoms of potential SARS-CoV-2 infection
Detection Principle
ImmunoAssay-Antigen
Target
nucleocapsid protein
Testing Method Category
Testing Method
kit (LFA immunochromatography assay)
Testing Method - Additional Info
Panbio™ COVID-19 Ag Rapid Test (Abbott)
Reported Performance
specificity: 100%; sensitivity: 72.6% (NL), 81% (Aruba), >95% (nasopharyngeal samples)
Sample Size
1367 (NL) & 208 (Aruba) samples
Peer-reviewed
no
The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements